FIELD: biotechnology.
SUBSTANCE: invention relates to a genetically modified mouse containing all human IGHV genes in an endogenous immunoglobulin heavy chain gene locus, all human IGHD genes and all human IGHJ genes in human chromosome 14 immunoglobulin heavy chain gene locus, as well as to its cell.
EFFECT: invention is effective for producing humanised antibodies.
14 cl, 82 dwg, 16 tbl, 17 ex
| Title | Year | Author | Number |
|---|---|---|---|
| GENETICALLY MODIFIED NON-HUMAN ANIMALS COMPRISING COMMON IMMUNOGLOBULIN LIGHT CHAIN LOCUS | 2021 |
|
RU2841160C1 |
| ANTIBODY-PRODUCING NON-HUMAN MAMMALS | 2009 |
|
RU2559524C2 |
| ANTIBODY-PRODUCING NON-HUMAN MAMMALS | 2020 |
|
RU2820926C2 |
| PRODUCING NON-HUMAN MAMMALIAN ANTIBODIES | 2009 |
|
RU2731084C2 |
| COLLECTION AND METHODS OF ITS APPLICATION | 2010 |
|
RU2569187C2 |
| ANTIBODIES AND OTHER MOLECULES BINDING B7-H1 AND PD-1 | 2012 |
|
RU2625034C2 |
| HUMANIZED NON-HUMAN ANIMALS WITH RESTRICTED IMMUNOGLOBULIN HEAVY CHAIN LOCI | 2013 |
|
RU2656155C2 |
| MICE WITH HUMANIZED LIGHT CHAIN | 2012 |
|
RU2761639C2 |
| MICE, EXPRESSING LIGHT CHAIN WITH VARIABLE REGION OF ALPHA HUMAN AND CONSTANT AREA OF MOUSE | 2011 |
|
RU2590594C2 |
| HUMANIZED RODENTS FOR TESTING THERAPEUTIC AGENTS | 2019 |
|
RU2805212C2 |
